𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis

✍ Scribed by Edoardo Missiaglia; Ekaterini Blaveri; Benoit Terris; Yao-He Wang; Eithne Costello; John P. Neoptolemos; Tatjana Crnogorac-Jurcevic; Nicholas R. Lemoine


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
906 KB
Volume
112
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Pancreatic cancer is a highly aggressive type of malignancy and the prognosis for disease presenting typically at a late stage is extremely poor. A comprehensive understanding of its molecular genetics is required in order to develop new approaches to clinical management. To date, serial analysis of gene expression and more recently oligo/cDNA microarray technologies have been employed in order to identify genes involved in pancreatic neoplasia that can be developed as diagnostic markers and drug targets for this dismal disease. This study describes the expression profile obtained from 20 pancreatic cell lines using cDNA microarrays containing 9,932 human gene elements. Numerous genes were identified as being differentially expressed, some of which have been previously implicated in pancreatic adenocarcinoma (S100P, S100A4, prostate stem cell antigen, lipocalin 2, claudins 3 and 4, trefoil factors 1 and 2) as well as several novel genes. The differentially expressed genes identified are involved in a variety of cellular functions, including control of transcription, regulation of the cell cycle, proteolysis, cell adhesion and signaling. Validation of our array results was performed by exploring the SAGEmap database and by immunohistochemistry for a selection of 4 genes that have not previously been studied in pancreatic cancer: anterior gradient 2 homologue (Xenopus laevis), insulin‐like growth factor binding protein 3 and 4 and Forkhead box J1. Immunostaining was performed using pancreas‐specific tissue microarrays containing core biopsies from 305 clinical specimens. In addition, using statistical group comparison and hierarchical clustering, a selection of genes was identified that may be linked to the site of metastasis from which these cell lines were isolated. Β© 2004 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Tissue array analysis of expression micr
✍ VΓ©ronique Ouellet; Marie-Claude Guyot; CΓ©cile Le Page; Abdelali Filali-Mouhim; C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 368 KB πŸ‘ 2 views

## Abstract Molecular profiling is a powerful approach to identify potential clinical markers for diagnosis and prognosis as well as providing a better understanding of the biology of epithelial ovarian cancer. On the basis of the analysis of HuFL expression data, we have previously identified gene

Analysis of genomic DNA alterations and
✍ Stephan Gysin; Paula Rickert; Kumar Kastury; Martin McMahon πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 480 KB

## Abstract Genomic alterations influencing the expression and/or activity of tumor suppressors or oncogenes such as __KRAS2__, __CDKN2A__, __TP53,__ and __DPC4__ have been directly implicated in the initiation and progression of human pancreatic adenocarcinoma. In an effort further to systematical

Gene expression profiles in primary ovar
✍ Alessandro D. Santin; Fenghuang Zhan; Stefania Bellone; Michela Palmieri; Stefan πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 550 KB

## Abstract With the goal of identifying genes with a differential pattern of expression between ovarian serous papillary carcinomas (OSPCs) and normal ovarian (NOVA) epithelium and using this knowledge for the development of novel diagnostic and therapeutic markers for ovarian cancer, we used olig

Evaluation of the tetracycline-repressib
✍ Gschwend, JΓΌrgen E.; Fair, William R.; Powell, C. Thomas πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 330 KB πŸ‘ 2 views

## BACKGROUND. Studies of genes that may inhibit growth or induce death of cells are facilitated greatly by tightly controlled expression of those genes. A promising system for control of transgene expression over a wide range is the tetracycline-repressible transactivator (tTA) system developed b